Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Influenza A induces dysfunctional immunity and death in MeCP2-overexpressing mice
James C. Cronk, Jasmin Herz, Taeg S. Kim, Antoine Louveau, Emily K. Moser, Ashish K. Sharma, Igor Smirnov, Kenneth S. Tung, Thomas J. Braciale, Jonathan Kipnis
James C. Cronk, Jasmin Herz, Taeg S. Kim, Antoine Louveau, Emily K. Moser, Ashish K. Sharma, Igor Smirnov, Kenneth S. Tung, Thomas J. Braciale, Jonathan Kipnis
View: Text | PDF
Research Article Immunology Inflammation

Influenza A induces dysfunctional immunity and death in MeCP2-overexpressing mice

  • Text
  • PDF
Abstract

Loss of function or overexpression of methyl-CpG-binding protein 2 (MeCP2) results in the severe neurodevelopmental disorders Rett syndrome and MeCP2 duplication syndrome, respectively. MeCP2 plays a critical role in neuronal function and the function of cells throughout the body. It has been previously demonstrated that MeCP2 regulates T cell function and macrophage response to multiple stimuli, and that immune-mediated rescue imparts significant benefit in Mecp2-null mice. Unlike Rett syndrome, MeCP2 duplication syndrome results in chronic, severe respiratory infections, which represent a significant cause of patient morbidity and mortality. Here, we demonstrate that MeCP2Tg3 mice, which overexpress MeCP2 at levels 3- to 5-fold higher than normal, are hypersensitive to influenza A/PR/8/34 infection. Prior to death, MeCP2Tg3 mice experienced a host of complications during infection, including neutrophilia, increased cytokine production, excessive corticosterone levels, defective adaptive immunity, and vascular pathology characterized by impaired perfusion and pulmonary hemorrhage. Importantly, we found that radioresistant cells are essential to infection-related death after bone marrow transplantation. In all, these results demonstrate that influenza A infection in MeCP2Tg3 mice results in pathology affecting both immune and nonhematopoietic cells, suggesting that failure to effectively respond and clear viral respiratory infection has a complex, multicompartment etiology in the context of MeCP2 overexpression.

Authors

James C. Cronk, Jasmin Herz, Taeg S. Kim, Antoine Louveau, Emily K. Moser, Ashish K. Sharma, Igor Smirnov, Kenneth S. Tung, Thomas J. Braciale, Jonathan Kipnis

×

Figure 4

Bone marrow transplant does not induce or rescue mortality, and influenza A infection in MeCP2Tg3 mice leads to vascular pathology.

Options: View larger image (or click on image) Download as PowerPoint
Bone marrow transplant does not induce or rescue mortality, and influenz...
(A) Survival curve for mice infected with influenza A/PR/8/34 that were given bone marrow transplant with MeCP2Tg3 or wild-type bone marrow. n = 28 for WT→WT, n = 23 for Tg3→WT, n = 16 for WT→Tg3, and n = 18 for Tg3→Tg3. ***P < 0.001 by log-rank (Mantel-Cox) test. ns, not significant. (B) Flow cytometry of RBCs in bronchoalveolar lavage (BAL) fluid on day 5 post infection (p.i.). Mock infected, n = 4 wild type and 3 MeCP2Tg3. Day-5 infected, n = 7 wild type and 4 MeCP2Tg3. Quantification on right shows percentage of cells expressing the erythroid marker Ter119 (mean ± SEM). ***P < 0.001 by 2-way ANOVA with Bonferroni post test. (C) Gross appearance of wild-type and MeCP2Tg3 lungs on day 7 p.i. (D) Images and quantification of Evans Blue dye (EBD) in BAL fluid taken from uninfected, day 5 p.i., and day 7 p.i. Mice were injected with EBD 1 hour prior to harvest. For day 0, n = 3 wild type and 3 MeCP2Tg3. For day-5 infected, n = 3 wild type and 4 MeCP2Tg3. For day-7 infected, n = 5 wild type and 4 MeCP2Tg3. Mean ± SEM. **P < 0.01 by 2-way ANOVA with Bonferroni post test. (E) Gross appearance of lungs from mice given EBD and analyzed 1 hour later. Lungs were perfused to remove remaining vascular dye and blood, and BAL fluid was taken. Images are representative of n = 3 mice per group for uninfected, and n = 4 mice per group for day 7 p.i. (F) Total BAL cell counts (mean ± SEM) on day 3 and day 8 p.i. n = 3 mice per group. **P < 0.01 by 2-way ANOVA with Bonferroni post test. ns, not significant. (G) Resistance, compliance, and pulmonary artery pressure measured on day 8 p.i. n = 5 for wild type and 3 for MeCP2Tg3; mean ± SEM. **P = 0.0074 by 2-tailed Student’s t test. (H) H&E staining of day 7 p.i. lungs that were not perfused or inflated demonstrates both arterial narrowing and perivascular edema (black arrowheads, pulmonary arteries). Representative of 2 experiments with at least n = 3 mice per group. Scale bar: 200 μm for large images, and 50 μm for insets.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts